
1.19 Delayed Data As of Jun 02 | ![]() Today’s Change | 0.53 Today|||52-Week Range 1.82 | +105.35% Year-to-Date |
The 4 analysts offering 12-month price forecasts for Adverum Biotechnologies Inc have a median target of 3.00, with a high estimate of 6.00 and a low estimate of 2.00. The median estimate represents a +152.10% increase from the last price of 1.19.
The current consensus among 5 polled investment analysts is to Buy stock in Adverum Biotechnologies Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.